Sorrento therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Sorrento therapeutics Contact Number

Contact Sorrento Therapeutics

1 hours ago Sorrentotherapeutics.com Show details

(858) 203-4100Sorrento Therapeutics, Inc. 4955 Directors Place San Diego, CA 92121. Tel: (858) 203-4100 Fax: (858) 203-4028. [email protected]sorrentotherapeutics.com

1. 4955 Directors Pl, San Diego, CA 92121 · (858) 203-4100DIRECTIONSWEBSITE

Category: Contact SupportShow more

Sorrento Therapeutics Company Contact Information Email

8 hours ago Adapt.io Show details

Get Sorrento Therapeutics company's verified contact number +1*****700, web address, revenue, total contacts 193, industry Healthcare, Pharmaceuticals, & Biotech and location at Adapt.io

Rating: 5/5(1)

Category: Contact SupportShow more

Sorrento Therapeutics Crunchbase Company Profile & …

1 hours ago Crunchbase.com Show details

(858) 210-3759Number of Exits 1. Contact Email [email protected]sorrentotherapeutics.com. Phone Number (858) 210-3759. Sorrento Therapeutics is a development-stage biopharmaceutical company engaged in the acquisition, discovery, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs.

Founded: 2006
Founder: Dr Henry Ji

Category: Contact NumberShow more

Sorrento Therapeutics, Inc. (SRNE) Company Profile

6 hours ago Stockanalysis.com Show details

Company profile for Sorrento Therapeutics, Inc. (SRNE) with a description, list of executives, contact details and other key facts. Company profile for Sorrento Therapeutics, Inc. (SRNE) with a description, list of executives, contact details and other key facts. CUSIP Number: 74838K108: ISIN Number: US83587F2020: Employer ID: 33-0344842

Category: Contact NumberShow more

SORRENTO THERAPEUTICS, INC. : Regulation FD Disclosure

5 hours ago Marketscreener.com Show details

Item 7.01. Regulation FD Disclosure. On December 6, 2021, Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., issued a press release announcing the signing of a letter December 6, 2021

Category: Contact NumberShow more

EIN 330344842 Sorrento Therapeutics, Inc., San Diego

9 hours ago Eintaxid.com Show details

Sorrento Therapeutics, Inc. is a corporation in San Diego, California. The employer identification number (EIN) for Sorrento Therapeutics, Inc. is 330344842. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

Doing Business As: Sorrento Therapeutics Inc
Organization Name: Sorrento Therapeutics, Inc.
IRS EIN (Taxpayer Id): 33-0344842

Category: Contact NumberShow more

Sorrento Therapeutics, Inc. Email Format

8 hours ago Rocketreach.co Show details

Sorrento Therapeutics, Inc. uses 1 email formats. The most common Sorrento Therapeutics, Inc. email format is first_initial last (ex. [email protected]) being used 100.0% of the time. Get Verified Emails for Sorrento Therapeutics, Inc. Employees. Sorrento Therapeutics, Inc.'s …

Category: Contact NumberShow more

Sorrento Therapeutics Inc – The Wall Street Facts

7 hours ago Wallstreetfacts.com Show details

The 52-week high for Sorrento Therapeutics Inc is $17.25 and the low is $5.17. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

$SRNE: New data is out now for Sorrento Therapeutics Inc

6 hours ago Wallstreetfacts.com Show details

The 52-week high for Sorrento Therapeutics Inc is $17.25 and the low is $5.17. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

Sorrento Announces That COVISTIX™ (COVID19 Virus Rapid

6 hours ago Investors.sorrentotherapeutics.com Show details

SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that it has received an official CE Mark for COVISTIX and a Registration Number: BE/CA01/1-17633-00001-IVD. COVISTIX is a sensitive and rapid (approximately 15-minute) diagnostic test for the detection of the SARS-CoV-2 virus

Category: Contact NumberShow more

Sorrento Therapeutics Inc. (NASDAQ: SRNE) Publishes

2 hours ago Biopharmajournal.com Show details

3 hours ago · Sorrento Therapeutics Inc. (NASDAQ: SRNE) has published a Teaser entitled “Abivertiniv- a Franchise oral therapeutics for Cancer, COVID-190 and autoimmune Diseases.” The company plans to use the Abivertinib Teaser to engage in negotiations with interested third-party pharmaceutical industry players.

Category: Contact NumberShow more

Sorrento Therapeutics, Inc. (SRNE) Company Profile & Facts

4 hours ago Finance.yahoo.com Show details

Sorrento Therapeutics, Inc. was founded in 2006 and is based in San Diego, California. Corporate Governance Sorrento Therapeutics, Inc.’s ISS Governance QualityScore as of September 26, 2021 is 9.

Category: Contact NumberShow more

Bill Farley Vice Presiden.. Sorrento Therapeutics

9 hours ago Zoominfo.com Show details

View Bill Farley's business profile as Vice President, Business & Corporate Development at Sorrento Therapeutics. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

Sorrento Therapeutics Number of Employees 20082021 SRNE

8 hours ago Macrotrends.net Show details

Number of Employees. Sorrento Therapeutics number of employees from 2008 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Compare SRNE With Other Stocks. Sorrento Therapeutics Annual Number of Employees. 2020. 502. 2019.

Category: Contact NumberShow more

Sorrento Therapeutics, Inc. Vs Patrick SoonShiong, Et Al

1 hours ago Trellis.law Show details

Overview in the case of Sorrento Therapeutics, Inc. Vs Patrick Soon-Shiong, Et Al. number 19STCV11328 in losangeles, ca

Category: Contact NumberShow more

STI Code of Business Conduct and Sorrento Therapeutics

3 hours ago Sorrentotherapeutics.com Show details

12.29.235

Category: Contact NumberShow more

Jobs with Sorrento Therapeutics, Inc. BioSpace

8 hours ago Biospace.com Show details

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that it has received an official CE Mark for COVISTIX and a Registration Number: BE/CA01/1-17633-00001-IVD. Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2 Antibody Drug Conjugate (TROP-2 ADC) for multiple solid tumors

Category: Contact NumberShow more

What Do Analysts Say About Sorrento Therapeutics Inc

4 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 290.00 million. SRNE does have institutional investors; and they hold 26.00% of the stock. Sorrento Therapeutics Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 6 new insider purchases involving 235,357 shares.

Category: Contact NumberShow more

Sorrento Therapeutics Funding, Financials, Valuation

Just Now Crunchbase.com Show details

Sorrento Therapeutics has raised a total of $264.4M in funding over 8 rounds. Their latest funding was raised on Oct 9, 2019 from a Post-IPO Equity round. Sorrento Therapeutics is registered under the ticker NASDAQ:SRNE . Their stock opened with $7.25 in its Jan 11, 2010 IPO.

Category: Contact NumberShow more

Sorrento Therapeutics Mexico Executes Contract for Sale of

2 hours ago Finance.yahoo.com Show details

SAN DIEGO and MEXICO CITY, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today its subsidiary, Sorrento Therapeutics Mexico, has executed a

Category: Contact NumberShow more

Will Sorrento Therapeutics (SRNE) Report Negative Q3

8 hours ago Finance.yahoo.com Show details

For the last reported quarter, it was expected that Sorrento Therapeutics would post a loss of $0.20 per share when it actually produced a loss of $0.33, delivering a surprise of -65%.

Category: Contact NumberShow more

Sorrento Therapeutics, Inc. (SRNE): Just so you know.

2 hours ago Investorshub.advfn.com Show details

SORRENTO THERAPEUTICS, INC. will be hosting a Virtual Stockholder Meeting this year. The meeting will be held at 12:00 PM Pacific Time on Monday, November 15, 2021 and stockholders of record will be able to vote and ask questions online during the meeting. If you would like to attend the virtual meeting and you have your control number, please

Category: Contact NumberShow more

Lisa Kerwin Associate Sci.. Sorrento Therapeutics

9 hours ago Zoominfo.com Show details

View Lisa Kerwin's business profile as Associate Scientist at Sorrento Therapeutics. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

$10.95 Million in Sales Expected for Sorrento Therapeutics

7 hours ago Marketbeat.com Show details

Is Sorrento Therapeutics (NASDAQ:SRNE) More Than Just A COVID-19 Play; A number of research analysts have issued reports on SRNE shares. HC Wainwright restated a "buy" rating and set a $25.00 price target on shares of Sorrento Therapeutics in a research note on Monday, November 15th. Zacks Investment Research lowered shares of Sorrento

Category: Contact NumberShow more

Current Report Filing (8k)

3 hours ago Ih.advfn.com Show details

2 days ago · SRNE Sorrento Therapeutics Inc Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of …

Category: Contact NumberShow more

Should You Buy Sorrento Therapeutics Inc (SRNE) in

3 hours ago Investorsobserver.com Show details

Sorrento Therapeutics Inc is near the middle in its industry group according to InvestorsObserver.SRNE gets an overall rating of 43. That means it scores higher than 43 percent of stocks. Sorrento Therapeutics Inc gets a 61 rank in the Biotechnology industry. Biotechnology is number 88 out of 148 industries.

Category: Contact NumberShow more

srne10q_20210331.htm SEC

7 hours ago Sec.gov Show details

The number of shares of the issuer’s common stock, par value $0.0001 per share, outstanding as of April 30, 2021 was 286,650,738. Sorrento Therapeutics, Inc. Form 10-Q for the Quarter Ended March 31, 2021

Category: Contact NumberShow more

Sorrento Therapeutics Announces Entry Into Option Agreement

2 hours ago Globenewswire.com Show details

Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University. M Pro is

Category: Contact NumberShow more

Sorrento Announces Dosing of COVID19 Patients in Phase 2

8 hours ago Investors.sorrentotherapeutics.com Show details

Variants of interest, such as Lambda (Peru) and others are constantly evaluated in Sorrento’s active surveillance program. About Sorrento Therapeutics, Inc. Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers and COVID-19.

Category: Contact NumberShow more

Sorrento Receives Brazilian Health Regulatory Agency

8 hours ago Marketscreener.com Show details

About Sorrento Therapeutics, Inc. Contact Alexis Nahama, DVM (SVP Corporate Development) Email: [email protected] Number of Analysts: 1: Last Close Price: 6,42 $ Average target price: 26,00 $ Spread / Average Target: 305%: Consensus. EPS Revisions

Category: Contact NumberShow more

Sorrento Therapeutics Welcomes Jiong Shao as Chief

5 hours ago Investors.sorrentotherapeutics.com Show details

SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced today that it appointed Mr Jiong Shao as Executive Vice President and Chief Financial Officer.. Jiong is an 18-year veteran in investment banking who has held a number of senior positions with several global leading investment banks in both New York and Hong …

Category: Contact NumberShow more

Sorrento Therapeutics Inc. (NASDAQ: SRNE) Analysts

2 hours ago Stocksregister.com Show details

The number of analysts that have assigned SRNE a recommendation rating is 2. Out of them, 0 rate it a Hold, while 2 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Sorrento Therapeutics Inc. (SRNE) as Underweight, while 0 advise Sell.

Category: Contact NumberShow more

What is Wall Street's Target Price for Sorrento

6 hours ago Investorsobserver.com Show details

Sorrento Therapeutics Inc (SRNE) stock is up 1.46% while the S&P 500 is lower by -0.16% as of 9:57 AM on Wednesday, Oct 13. SRNE is higher by $0.09 from the previous closing price of $6.52 on volume of 506,424 shares. Over the past year the S&P 500 has gained 23.69% while SRNE is lower by -44.60%.

Category: Contact NumberShow more

Sorrento Announces That COVISTIX™ (COVID19 Virus Rapid

2 hours ago Finance.yahoo.com Show details

SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that it has received an official CE Mark for COVISTIX and a Registration Number

Category: Contact NumberShow more

srne8k_20201014.htm SEC

6 hours ago Sec.gov Show details

150 33-0344SORRENTO THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36150 33-0344842 (State or Other Jurisdiction. of Incorporation) (Commission. File Number) (IRS Employer

Category: Contact NumberShow more

Statement of Changes in Beneficial Ownership (4)

4 hours ago Ih.advfn.com Show details

Nature of Indirect Beneficial Ownership (Instr. 4) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.03, inclusive.

Category: Contact NumberShow more

This Is A Time To Build A Position In Sorrento

7 hours ago Marketingsentinel.com Show details

Sorrento Therapeutics Inc. (NASDAQ:SRNE)’s traded shares stood at 1.17 million during the latest session, with the company’s beta value hitting 2.40. At the last check today, the stock’s price was $6.61, to imply an increase of 4.01% or $0.25 in …

Category: Contact NumberShow more

Sorrento Therapeutics Announces Entry Into Option

5 hours ago Apnews.com Show details

Sorrento may exercise its right to enter into a worldwide exclusive license agreement at any time during the option period. About Sorrento Therapeutics, Inc. Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers and COVID-19.

1. Author: Sorrento Therapeutics, Inc.

Category: Contact NumberShow more

Sorrento Therapeutics: Wide Oncology Pipeline, And Watch

7 hours ago Seekingalpha.com Show details

Sorrento, which is normally associated with COVID-19, but the number of therapeutic areas the biotech is working in shows that it has a much …

Category: Contact NumberShow more

Will Sorrento Therapeutics (SRNE) Report Negative Q3

3 hours ago Entrepreneur.com Show details

For the last reported quarter, it was expected that Sorrento Therapeutics would post a loss of $0.20 per share when it actually produced a loss of $0.33, delivering a surprise of …

Category: Contact NumberShow more

Sorrento Escapes COVID19 Investor Class Action Law360

7 hours ago Law360.com Show details

The case is In re Sorrento Therapeutics Inc. Securities Litigation, case number 3:20-cv-00966, in the U.S. District Court for the Southern District of California. --Editing by Gemma Horowitz.

Category: Contact NumberShow more

Sorrento Therapeutics Lobbyists • OpenSecrets

8 hours ago Opensecrets.org Show details

Non Former Members of Congress. Tauzin Strategic Networks. $10,000. Sorrento Therapeutics. Billy Tauzin. Revolving Door Profiles. Former Members of Congress. Revolving Door Profile Former Member of Congress. NOTE: Figures on this page are calculations by OpenSecrets based on data from the Senate Office of Public Records.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What does Sorrento Therapeutics do?

Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex.

What is the ISS governance qualityscore for Sorrento Therapeutics?

Sorrento Therapeutics, Inc.’s ISS Governance QualityScore as of July 1, 2021 is 9. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 6; Compensation: 10. Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region.

Why partner with Sorrento?

At Sorrento, we seek strong partnerships and collaborations as a critical driver of our strategy to push the boundaries of science and deliver life-changing therapies to patients so they can live healthier and happier lives.

How many biobetters does Sorrento commercialize?

Sorrento has an exclusive license to commercialize four Biobetters that have completed Phase 3 studies in China for the North American, European and Japan markets

Popular Brands

Sharp
Shell
Sap
Sgs
Sabb
Sea